Billionaire Texan Heir Is Helping Bring Back the Woolly Mammoth
A Texas oil heir’s quest to make Dallas a hub for biotech is showing signs of paying off,
2023-12-01 22:18
Novo Nordisk finds compounded Wegovy up to 33% impure, sues Florida pharmacies
By Patrick Wingrove (Reuters) -Novo Nordisk said on Thursday it sued one compounding pharmacy and refiled a lawsuit against another
2023-12-01 15:48
Explainer-Why prior mega health insurer deals like the possible Cigna/Humana merger failed
WASHINGTON U.S. health insurers Cigna and Humana are in talks to merge, a potential deal likely to face
2023-12-01 05:49
US health insurers Humana, Cigna in talks to merge -source
By Anirban Sen and Deena Beasley (Reuters) -U.S. health insurer Cigna is in talks to merge with peer Humana, a
2023-11-30 07:57
3M, DuPont defeat massive class action over forever chemicals
By Clark Mindock (Reuters) -A U.S. appeals court on Monday handed 3M, Corteva Inc subsidiary E.I. du Pont de Nemours
2023-11-28 08:46
Bond Market’s Dramatic Recovery Is Seen as Opening Act for Broader Revival
The world’s biggest bond market has clawed its way back after spending chunks of 2023 underwater. Now many
2023-11-27 04:17
Altman Returns as OpenAI’s CEO With Summers on Board
OpenAI will bring back Sam Altman and overhaul its board to bring on new directors including Larry Summers,
2023-11-22 15:29
Medtronic raises fiscal 2024 forecast on strong sales of surgical, diabetes devices
By Khushi Mandowara and Christy Santhosh Medtronic beat second-quarter profit and revenue estimates and raised its annual earnings
2023-11-21 21:51
Walgreens to close nearly all pharmacies on Thanksgiving for first time
(Reuters) -Walgreens Boots Alliance will close nearly all of its stores and pharmacies on Thanksgiving Day for the first time
2023-11-17 04:53
Contract drugmaker Catalent shows signs of recovery in Q1 revenue beat
(Reuters) -Catalent beat Wall Street's estimates for first-quarter revenue on Wednesday, as the contract drug manufacturer showed signs of improvement
2023-11-15 21:52
Biogen cuts annual profit forecast on higher deal costs (Nov 8)
(This Nov. 8 story has been corrected to say Biogen cut profit forecast due to costs related to a deal,
2023-11-15 07:53
Catalent delays quarterly filing with SEC on $700 million impairment charge
Catalent will delay its quarterly filing with the U.S. securities regulator due to a goodwill impairment charge of
2023-11-14 22:59